With recent advances in technology, patients with acute respiratory distress syndrome (ARDS) could benefit from extracorporeal CO2 removal (ECCO2R). However, current evidence in these indications is limited.
Organised by the Acute Respiratory Failure (ARF) ESICM Section, this webinar discussed the benefits and potential complications associated with ECCO2R in ARDS.
- Describe the variability and determinants of ECCO2R on tidal volume, driving pressure, and mechanical power.
- Review the latest literature and clinical data on the use of ECCO2R in ARDS and which patients could benefit from it.
- Learn more about the spectrum of risks correlated with ECCO2R.
Topics & Experts
“Determinants of CO2 removal during ECCO2R”
Prof Christian KARAGIANNIDIS
Cologne-Merheim Medical Center (CMMC), Witten/Herdecke University (DE).
“Current evidence and risks of ECCO2R in ARDS”
Prof Marco RANIERI
Policlinico Sant’Orsola Malpighi di Bologna (IT). ESICM Past President.
Dr Luigi CAMPOROTA
Guy’s & St Thomas’ NHS Foundation Trust, London (UK). Chair, ESICM ARF Section.